Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Korro Bio (KRRO) Change in Accured Expenses (2019 - 2025)

Historic Change in Accured Expenses for Korro Bio (KRRO) over the last 7 years, with Q3 2025 value amounting to $189000.0.

  • Korro Bio's Change in Accured Expenses rose 12639.66% to $189000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $477000.0, marking a year-over-year increase of 10912.92%. This contributed to the annual value of -$4.0 million for FY2024, which is 41251.97% down from last year.
  • Korro Bio's Change in Accured Expenses amounted to $189000.0 in Q3 2025, which was up 12639.66% from $2.0 million recorded in Q2 2025.
  • Over the past 5 years, Korro Bio's Change in Accured Expenses peaked at $2.0 million during Q2 2025, and registered a low of -$5.0 million during Q1 2024.
  • Over the past 5 years, Korro Bio's median Change in Accured Expenses value was $357000.0 (recorded in 2022), while the average stood at -$181842.1.
  • Per our database at Business Quant, Korro Bio's Change in Accured Expenses skyrocketed by 76711.11% in 2023 and then tumbled by 35192.48% in 2024.
  • Korro Bio's Change in Accured Expenses (Quarter) stood at $804000.0 in 2021, then crashed by 55.6% to $357000.0 in 2022, then tumbled by 228.85% to -$460000.0 in 2023, then skyrocketed by 273.04% to $796000.0 in 2024, then plummeted by 76.26% to $189000.0 in 2025.
  • Its last three reported values are $189000.0 in Q3 2025, $2.0 million for Q2 2025, and -$2.5 million during Q1 2025.